{"@id":"https://bioecon.ru/technology/car-t-potentiation-via-mitochondria/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://bioecon.ru/technology/car-t-potentiation-via-mitochondria/","json":"https://bioecon.ru/api/v1/technology/car-t-potentiation-via-mitochondria/index.json"},"id":"car-t-potentiation-via-mitochondria","industries":["pharma","biomanufacturing"],"lang":"ru","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/johnson-johnson/","https://bioecon.ru/companies/san-diego-sa/","https://bioecon.ru/companies/impacfat/","https://bioecon.ru/companies/ingenio-risaralda-sa/","https://bioecon.ru/companies/wildtype/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/ipiranga-agroindustrial-sa/"]},"maturity":7,"name":"Потенциация CAR-T-клеток митохондриальным переносом","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Выделение интактных митохондрий"},{"n":2,"title":"Микрофлюидная доставка органелл"},{"n":3,"title":"Оценка метаболического репрограммирования"},{"n":4,"title":"Выживаемость в солидных опухолях"}],"summary":"Перенос интактных функциональных митохондрий из здоровых стволовых клеток в терапевтические CAR-T клетки, переводящий их на окислительное фосфорилирование и предотвращающий истощение в опухоли.","url":"/technology/car-t-potentiation-via-mitochondria/","verified":"2026-11-22"}